(Q43837238)

27 November 2017

title

Sensitive analysis of 1alpha,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry (English)

1 reference

liquid chromatography-tandem mass spectrometry

27 November 2017

main subject

1 reference

Kissmeyer AM

1

1 reference

27 November 2017

Sonne K

series ordinal

2

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of Chromatography

27 November 2017

published in

1 reference

27 November 2017

volume

935

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

93-103

1 reference

describes a project that uses

27 November 2017

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

The Cutaneous Photosynthesis of Previtamin D3: A Unique Photoendocrine System

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

The role of the vitamin D endocrine system in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Calcipotriol: a new drug for topical psoriasis treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1 alpha,24-dihydroxycholecalciferol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

1,25-Dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Effect of ED-71 on modeling of bone in distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Renal osteodystrophy: new insights in pathophysiology and treatment modalities with special emphasis on the insulin-like growth factor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Quantitative determination of F6-1,25(OH)2 vitamin D3 in human serum by gas chromatography/mass spectrometry with high-resolution selected ion monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Radioimmunoassay method for the determination of 22-oxacalcitriol, a novel analog of 1 alpha,25-dihydroxyvitamin D3 having valuable clinical potency, in rat and human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

A selective immunoaffinity chromatography for determination of plasma 1 alpha, 25-dihydroxyvitamin D3: application of specific antibodies raised against a 1 alpha, 25-dihydroxyvitamin D3-bovine serum albumin conjugate linked through the 11 alpha-pos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

A highly sensitive method for large-scale measurements of 1,25-dihydroxyvitamin D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Determination of the vitamin D analog EB 1089 (seocalcitol) in human and pig serum using liquid chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Determination of 22-oxacalcitriol, a new analog of 1alpha,25-dihydroxyvitamin D3, in human serum by liquid chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Metabolism of the vitamin D analog EB 1089: identification of in vivo and in vitro liver metabolites and their biological activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Pharmacokinetics and metabolism of a vitamin D analogue (Seocalcitol) in rat and minipig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900985-2

10.1016/S0021-9673(01)00985-2

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference